»ó´Ü¿©¹é
±â»ç (Àüü 1,137°Ç)
[Sub Story] Çѱ¹ÀÎ MI ȯÀÚ ¡®¸ÂÃ㡯 Ç×Ç÷Àü¿ä¹ý Àû¿ë ÀÓ¼¼Çü ±âÀÚ 2021-01-04 17:05
[Interview] ¡°MI ȯÀÚ ½ÉºÎÀü ¿¹¹æ °¡´É¼º È®ÀÎÇß´Ù¡± ÀÓ¼¼Çü ±âÀÚ 2021-01-04 17:02
[Sub Story] LAMA/LABA, È£Èí°ï¶õ¡¤¾ÇÈ­¿¹¹æ ¸ðµÎ¿¡ È¿°ú ÀÓ¼¼Çü ±âÀÚ 2021-01-04 16:55
[Deep in Guideline] PPI Á᫐ ÁÖ¿ä ¾à¹°Ä¡·á ±Ç°í ÀÓ¼¼Çü ±âÀÚ 2021-01-04 14:44
[Conference Report] SPRINT ¿¬±¸ ¸ÂÃãÄ¡·á ÇâÇÑ ±â¹ÝµÈ´Ù ÀÓ¼¼Çü ±âÀÚ 2020-11-02 17:32
¶óÀÎ
[Sub Story] ³·¾ÆÁø ¸ñÇ¥Ç÷¾Ð,

¡®Á¶Àý·ü °³¼±¡¯ °úÁ¦·Î µ¹¾Æ¿À´Ù

ÀÓ¼¼Çü ±âÀÚ 2020-11-02 16:42
[Sub Story] °íÀ§Çè ȯÀÚ±º¿¡ ¸Å³â Ç÷¾ÐÃøÁ¤ °­Á¶ ÀÓ¼¼Çü ±âÀÚ 2020-11-02 16:01
[Sub Story] °¡¸é °íÇ÷¾Ð, º¹ÇÕÀû ¸ðµ¨ Æò°¡ ÇÊ¿äÇÏ´Ù ÀÓ¼¼Çü ±âÀÚ 2020-11-02 15:33
[Deep in Guideline] ½ÅÁßÇÑ Á¢±ÙÀü·« Á¦½Ã¡¤¼¼ºÎÀûÀÎ Ç×Ç÷¼ÒÆÇÀü·« Ãß°¡ ÀÓ¼¼Çü ±âÀÚ 2020-11-02 14:31
[Conference Report] ¡®È¯ÀÚ Á߽ɡ¯ °íÇ÷¾Ð + ÀÌ»óÁöÁúÇ÷Áõ °ü¸® °í·ÁÇØ¾ß ÀÓ¼¼Çü ±âÀÚ 2020-11-02 14:26
¶óÀÎ
[Drug Review] Ç×Ç÷ÀüÈ¿°ú ¹× ¾ÈÀü¼º ÀÔÁõµÈ À¯Å©¸®µåÁ¤ ÀÓ¼¼Çü ±âÀÚ 2020-10-13 09:46
[Conference Report] DPP-4¾ïÁ¦Á¦ Ä¡·á½ÇÆÐ, ¡®DPP-4¾ïÁ¦Á¦¡¯·Î º¸¿ÏÇÑ´Ù ÀÓ¼¼Çü ±âÀÚ 2020-10-13 09:44
[Interview] ¡°ASCVD¿¡¼­ ¡®¾ÈÀüÇÑ¡¯ Áß¼ºÁö¹æ °­ÇÏ ½ºÅ¸Æ¾ Àü·«¡± ÀÓ¼¼Çü ±âÀÚ 2020-10-13 09:43
[Sub Story] ½ºÅ¸Æ¾ NODM À§Çè °­µµº°·Î ´Ù¸£´Ù ÀÓ¼¼Çü ±âÀÚ 2020-10-12 18:30
[Late Breaking Studies] ÇÇŸ¹Ù½ºÅ¸Æ¾, °í°­µµ ½ºÅ¸Æ¾°ú À¯»çÇÑ ½É³úÇ÷°üÇýÅà º¸°í ÀÓ¼¼Çü ±âÀÚ 2020-10-12 18:29
¶óÀÎ
[Deep in Guideline] ȯÀÚ Áß½É Ä¡·áÀü·« °­Á¶ ÀÓ¼¼Çü ±âÀÚ 2020-10-12 17:12
[Conference Report] ¡°ÃâÇ÷ À§Çè ³ôÀº ³úÁ¹Áß¿¡¼­ ½Ç·Î½ºÅ¸Á¹ °í·Á¡± ÀÓ¼¼Çü ±âÀÚ 2020-10-12 16:51
[Late Breaking Studies] Ç÷Àü ¼ºÇâ, µ¿¾Æ½Ã¾ÆÀÎ-¹éÀÎ Çù½ÉÁõ ¿¹ÈÄ¿¡ ¿µÇâÀÖ´Ù ÀÓ¼¼Çü ±âÀÚ 2020-10-12 16:12
[Interview] ¡°ASCVD ¿¹¹æ¡¤°ü¸®, Áß¼ºÁö¹æµµ ÇÙ½ÉÀÎÀÚ´Ù¡± ÀÓ¼¼Çü ±âÀÚ 2020-10-12 16:10
[Deep in Guideline] 2´Ü°è Áø´ÜÀ¸·Î Ä¡¸Å Á¾·ù±îÁö ÆÄ¾Ç °­Á¶ ÀÓ¼¼Çü ±âÀÚ 2020-09-29 13:19
Back to Top